“…They show a variety of geometric shapes, including needles, rods, and polyhedral forms; they are of variable sizes; generally singly dispersed but may aggregate; they are generally eosinophilic and refractile. Amylase crystalloids are non birefringent and are often associated with benign lesions, especially those with oncocytic metaplasia, sialadenitis, and sialolithiasis, oncocytic neoplasms (e.g., Warthin, oncocytoma, oncocytic cystadenoma, and mixed tumor with oncocytic features) [2]. Amylase crystalloids were first described by Takeda and Ishikawa in 1983 where they confirmed the nature of the substance by scanning electron microscopy and electron probe X-ray microanalysis [5].…”